| Literature DB >> 31330079 |
Ensieh Nasli-Esfahani1, Maryam Mohammadi-Khanaposhtani2, Sepideh Rezaei3, Yaghoub Sarrafi4, Zeinab Sharafi5, Nasser Samadi6, Mohammad Ali Faramarzi6, Fatemeh Bandarian1, Haleh Hamedifar7, Bagher Larijani8, Mirhamed Hajimiri9, Mohammad Mahdavi8.
Abstract
A series of new Schiff bases bearing 1,2,3-triazole 12a-o was designed, synthesized, and evaluated as α-glucosidase inhibitors. All the synthesized compounds showed promising inhibition against α-glucosidase and were more potent than the standard drug acarbose. The kinetic study on the most potent compound 12n showed that this compound acted as a competitive α-glucosidase inhibitor. The docking study revealed that the synthesized compounds interacted with the important residues in the active site of α-glucosidase.Entities:
Keywords: 1,2,3-triazole; Schiff base; antidiabetic activity; molecular docking; α-glucosidase
Mesh:
Substances:
Year: 2019 PMID: 31330079 DOI: 10.1002/ardp.201900034
Source DB: PubMed Journal: Arch Pharm (Weinheim) ISSN: 0365-6233 Impact factor: 3.751